Fengxi Su

2 clinical trials · Sponsor

Record	Firm	Date
Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China (NCT04076111)	Fengxi Su	2019-09-05
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients (NCT02132000)	Fengxi Su	2014-04-01

Every clearance here is in the API, with alerts when new ones post.